GSK sees blockbuster potential in targeted cancer therapy after promising early data
British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told reporters, after early
April 12, 2026
7 killed and dozens injured following series of weekend shootings in Chicago
How a COVID lockdown helped make an award-winning winemaker in South Africa
Hezbollah chief says would respond to any violation from Israel
Kansas town embraces Algeria at the World Cup as the nation itself grapples with human rights record
Thousands of Czechs rally against a government plan to overhaul the funding of public broadcasters
'Toy Story 5' rakes in the biggest box-office debut of the year with a franchise-best $160 million
AI regulation is a mess, and Anthropic is caught in the crosshairs
Bolivia crisis begins to ease after lawmakers back state of emergency